EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases

Nanna Møller Jensen, Zagorka Vitic, Mia R Antorini, Tobias Bruun Viftrup, Laura Parkkinen, Poul Henning Jensen

Acta Neuropathologica · 2025

DOI: 10.1007/s00401-025-02871-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2025. Verfasst von Nanna Møller Jensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: DANDRITE - Danish Research Institute of Translational Neuroscience, Aarhus C, Denmark. nanna.mj@biomed.au.dk. Hauptthemen laut MEDLINE: alpha-Synuclein, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Lewy Body Disease, Lewy Bodies. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Lundbeck Foundation, Aarhus University Graduate School of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lewy body diseases are common neurodegenerative diseases, including Parkinson’s disease (PD) and dementia with Lewy bodies, which lead to both motor and non-motor symptoms. They are neuropathologically characterized by loss of neuromelanized neurons in the substantia nigra pars compacta and α-synuclein-immunopositive inclusions (Lewy bodies) in several types of neurons in the brain. A fraction of monogenic PD cases, however, represent a conundrum, as they can present with clinical Lewy body disease but do not have Lewy bodies upon neuropathological examination. For LRRK2, the presence or absence of Lewy bodies is not related to any specific mutation in the gene and different clinical presentation and neuropathology can be present even in the same family. Here, we present the first evidence of widespread α-synuclein accumulation detected with proximity ligation assay (PLA) using the MJFR14-6-4-2 antibody in six Lewy body-negative LRRK2 cases and compare the levels with five patients with neuropathologically verified Lewy body disease and six healthy controls. We show that non-inclusion aggregated α-synuclein in the form of particulate PLA signal is dominant in the LRRK2 cases, while both Lewy-like and particulate PLA signal is found in late-stage Lewy body disease. Furthermore, LRRK2 cases displayed prominent particulate PLA signal in pontocerebellar tracts and inferior olivary nuclei in the brainstem, which was not seen in idiopathic Lewy body disease cases. These results suggest that Lewy-body negative LRRK2-related PD is not associated with a lack of α-synuclein aggregation in neurons but rather a deficiency in the formation of inclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Lewy Body DiseaseLewy BodiesBrainHumansAgedMaleFemaleMutationAged, 80 and overMiddle AgedParkinson Disease

Stichwörter der Autor:innen

LRRK2Lewy body diseaseNeurodegenerationNon-inclusion pathologyProximity ligation assayα-Synuclein

Substanzen

alpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, human

Autor:innen und Institutionen

  • DANDRITE - Danish Research Institute of Translational Neuroscience, Aarhus C, Denmark. nanna.mj@biomed.au.dk.
  • Department of Biomedicine, Aarhus University, Aarhus C, Denmark. nanna.mj@biomed.au.dk.
  • DANDRITE - Danish Research Institute of Translational Neuroscience, Aarhus C, Denmark.
  • Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
  • Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK. laura.parkkinen@ndcn.ox.ac.uk.
  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. laura.parkkinen@ndcn.ox.ac.uk.

Förderung

  • Michael J. Fox Foundation for Parkinson's Research
  • Lundbeck Foundation
  • Aarhus University Graduate School of Health
  • GSK-Institute of Molecular and Computational Medicine
  • NIHR Oxford Biomedical Research Centre
  • National Institutes of Health
  • Parkinsonforeningen
  • Bjarne Saxhof Foundation

Zitieren

APA

Jensen, N. M., Vitic, Z., Antorini, M. R., Viftrup, T. B., Parkkinen, L., & Jensen, P. H. (2025). Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathologica. https://doi.org/10.1007/s00401-025-02871-w

Vancouver

Jensen NM, Vitic Z, Antorini MR, Viftrup TB, Parkkinen L, Jensen PH. Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02871-w

BibTeX
@article{Jensen2025,
  author = {Jensen, Nanna Møller and Vitic, Zagorka and Antorini, Mia R and Viftrup, Tobias Bruun and Parkkinen, Laura and Jensen, Poul Henning},
  title = {Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases},
  journal = {Acta Neuropathologica},
  year = {2025},
  doi = {10.1007/s00401-025-02871-w}
}
Kostenlos starten →